Quantcast
Last updated on April 17, 2014 at 11:11 EDT

Latest Spasmodic torticollis Stories

2013-01-21 12:23:26

OTTAWA, Jan. 21, 2013 /CNW/ - In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products revise their product labels to reflect that each product has its own individual potency and as such, is not interchangeable with other botulinum products. The labelling changes are due to a risk evaluation of the active ingredients (Clostridium botulinum...

2012-07-05 06:33:55

(Ivanhoe Newswire) — Botox — it´s not just for wrinkles! It´s been known to reduce fine lines, help chronic headaches, and reduce sweating. Now, it can help those suffering from multiple sclerosis (MS). According to new research, the Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with MS. "Treatments in use for tremor in MS are not sufficiently effective and new alternatives are needed," study author Anneke van der Walt, MD,...

2012-07-03 10:52:36

Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis (MS), according to new research published in the July 3, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. "Treatments in use for tremor in MS are not sufficiently effective and new alternatives are needed," said study author Anneke van der Walt, MD, consultant neurologist at The Royal Melbourne Hospital and research fellow with the...

2012-04-23 02:28:09

GREENSBORO, N.C., April 23, 2012 /PRNewswire/ -- Merz Pharmaceuticals today announced that initial baseline data from an ongoing Phase 4 Trial Evaluating XEOMIN® (incobotulinumtoxinA) for Cervical Dystonia (CD) and Blepharospasm in the United States (XCiDaBLE) will be presented at the 64th American Academy of Neurology (AAN) Annual Meeting in New Orleans, La. XEOMIN is approved for the treatment of cervical dystonia in adults, to decrease the severity of abnormal head position and neck...

2012-03-14 08:05:00

GREENSBORO, N.C., March 14, 2012 /PRNewswire/ -- Following a final hearing that occurred yesterday with the Honorable Andrew J. Guilford, the judge presiding over a recently concluded bench trial which focused on a commercial dispute over trade secrets, Merz is providing additional details on the outcome of the case. "We regret that this ruling will affect physicians and patients as we believe that access to quality FDA-approved treatment options, including XEOMIN®...

2012-03-12 11:31:27

New treatment for overactive bladder is trialed by the University of Leicester The biggest study into the treatment of urinary incontinence with botulinum toxin (trade name Botox) has demonstrated that it is effective in treating overactive bladder (OAB) - a debilitating common condition which can affect up to 20% of people over the age of 40. The study from the University of Leicester was led by Dr. Douglas Tincello, Senior Lecturer at the University and Honorary Consultant...

2012-03-05 23:08:04

Researchers have identified a gene that causes adult-onset primary cervical dystonia, an often-painful condition in which patients' necks twist involuntarily. The discovery by a team from the Jacksonville, Fla., campus of Mayo Clinic and the University of Tennessee Health Sciences Center sheds light on a movement disorder that physicians previously could seldom explain. In 1990, a man with a crooked neck came to see Ryan Uitti, M.D., a neurologist then at Mayo Clinic in Rochester, Minn....

2012-01-04 09:38:00

GREENSBORO, N.C., Jan. 4, 2012 /PRNewswire/ -- Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 "INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT" for Xeomin(®) (incobotulinumtoxinA), effective beginning January 1, 2012. The U.S. Food and Drug Administration (FDA) approved XEOMIN in July 2010 for the treatment of cervical dystonia in...

2011-12-23 17:10:00

Dr. Ingrid Warmuth is a specialist in many areas of dermatology and has been voted "Best Of The Best" by readers of the Vineland Daily Journal, and voted “Top Doc in South Jersey”. Elmer, New Jersey (PRWEB) December 23, 2011 Dr. Ingrid Warmuth is one of the selected providers for the early release of Xeomin. The Food and Drug Administration (FDA) recently approved this new botulinum toxin type A in July, 2011 for aesthetic indication; particularly to treat moderate to severe...

2011-11-17 11:30:00

FRANKFURT, Germany, Nov. 17, 2011 /PRNewswire/ -- Merz Pharmaceuticals today announced that results from five studies examining XEOMIN® (incobotulinumtoxinA), a botulinum neurotoxin type A preparation free from accessory proteins, will be presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) in Orlando, Fla. The first poster being presented at the meeting, titled "Sustained efficacy of incobotulinumtoxinA...